Next Century Growth Investors Portfolio holdings

Next Century Growth Investors's Q1 2020 Portfolio in Review

As of Q1 2020, Next Century Growth Investors held 143 positions worth $616M, down 20% from $769M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Next Century Growth Investors withdrew a net $21.8M in Q1 2020, closing 18 positions and reducing 47 holdings. Its most notable exit was Calavo Growers, an estimated $15.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Financials.

Against the trend, Next Century Growth Investors opened a new position in Axonics, Inc. Common Stock worth $4.37M.

• Next Century Growth Investors's largest Q1 2020 buy was Axonics, Inc. Common Stock: 171,944 shares worth $4.37M.
• Next Century Growth Investors added most to MACOM Technology Solutions in Q1 2020, an estimated $15.2M increase.
• Next Century Growth Investors's biggest Q1 2020 reduction was Inspire Medical Systems, cutting an estimated $10.6M.
• Next Century Growth Investors fully exited Calavo Growers in Q1 2020, selling an estimated $15.4M.
• Next Century Growth Investors's ten largest holdings make up 29% of its $616M portfolio in Q1 2020.
• Next Century Growth Investors opened 15 new positions and closed 18 in Q1 2020.
• Next Century Growth Investors's portfolio value fell 20% quarter-over-quarter to $616M.

Based on Next Century Growth Investors's 13F filing for Q1 2020, filed 14 May 2020.